World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
82
Citations
26326
World Ranking
1501
National Ranking
134

Overview

Michael Ewers is affiliated with the Ludwig-Maximilians-Universität München in Germany. Their research spans several fields of study within medicine and neuroscience, focusing heavily on cognitive neuroscience, psychiatry and mental health, physiology, radiology, nuclear medicine and imaging, as well as neurology.

The core topics within their work include dementia and cognitive impairment research, Alzheimer's disease research and treatments, functional brain connectivity studies, advanced neuroimaging techniques and applications, neurological disease mechanisms and treatments, neuroinflammation and neurodegeneration mechanisms, and neural dynamics and brain function.

Their recent papers highlight a range of contributions to neurological research:

  • "Neuroimaging standards for research into small vessel disease-advances since 2013" (2023, The Lancet Neurology)
  • "Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease" (2020, Nature Communications)
  • "Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank" (2021, Alzheimer s & Dementia)
  • "Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer's disease" (2020, Science Advances)
  • "Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation" (2020, EMBO Molecular Medicine)

The scientist frequently publishes in several venues, primarily in Alzheimer s & Dementia, bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, Brain, and Alzheimer s Research & Therapy.

Their frequent co-authors include Nicolai Franzmeier, Katharina Büerger, Anna Dewenter, Matthias Brendel, and Robert Perneczky, with numerous collaborations across these researchers.

Best Publications

  • Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance

    Yaakov Stern;Eider M. Arenaza-Urquijo;David Bartrés-Faz;Sylvie Belleville

  • CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

    Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen

  • Neuroimaging standards for research into small vessel disease—advances since 2013

    Unknown

  • CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

    Katharina Buerger;Michael Ewers;Tuula Pirttila;Raymond Zinkowski

  • Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.

    Katrin Jekel;Marinella Damian;Carina Wattmo;Lucrezia Hausner

  • Implementation of subjective cognitive decline criteria in research studies.

    José L. Molinuevo;Laura A. Rabin;Laura A. Rabin;Rebecca Amariglio;Rachel Buckley;Rachel Buckley;Rachel Buckley

  • sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

    Marc Suárez-Calvet;Marc Suárez-Calvet;Gernot Kleinberger;Miguel Ángel Araque Caballero;Matthias Brendel

  • Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

    Ganesh M. Babulal;Yakeel T. Quiroz;Benedict C. Albensi;Eider Arenaza-Urquijo

  • Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance

    Michael Ewers;Michael Ewers;Cathal Walsh;John Q. Trojanowski;Leslie M. Shaw

  • Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.

    Harald Hampel;Michael Ewers;Katharina Bürger;Peter Annas

  • Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

    Unknown

  • Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia

    Michael Ewers;Reisa A. Sperling;Reisa A. Sperling;William E. Klunk;Michael W. Weiner;Michael W. Weiner

  • Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease.

    Claudia Plant;Stefan J. Teipel;Stefan J. Teipel;Annahita Oswald;Christian Böhm

  • A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms

    Ebru Baykara;Benno Gesierich;Ruth Adam;Anil Man Tuladhar

  • Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology

    Marc Suárez-Calvet;Marc Suárez-Calvet;Estrella Morenas-Rodríguez;Estrella Morenas-Rodríguez;Gernot Kleinberger;Kai Schlepckow

  • Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Itziar de Rojas;Itziar de Rojas;Sonia Moreno-Grau;Sonia Moreno-Grau;Niccolo Tesi;Benjamin Grenier-Boley

  • Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease

    Michael Ewers;Nicolai Franzmeier;Marc Suárez-Calvet;Estrella Morenas-Rodriguez;Estrella Morenas-Rodriguez

  • Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury

    Marc Suárez-Calvet;Marc Suárez-Calvet;Miguel Ángel Araque Caballero;Gernot Kleinberger;Randall J. Bateman

  • The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk

    Yuetiva Deming;Yuetiva Deming;Fabia Filipello;Francesca Cignarella;Claudia Cantoni

  • Levels of β-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment

    Zhenyu Zhong;Michael Ewers;Stefan Teipel;Katharina Bürger

  • Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.

    Stefan J. Teipel;Christine Born;Michael Ewers;Arun L.W. Bokde

  • CSFBiomarkersandIncipientAlzheimerDisease in Patients With Mild Cognitive Impairment

    Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen

Frequent Co-Authors

Martin Dichgans
Martin Dichgans Ludwig-Maximilians-Universität München
Katharina Buerger
Katharina Buerger Ludwig-Maximilians-Universität München
Stefan J. Teipel
Stefan J. Teipel German Center for Neurodegenerative Diseases
Kaj Blennow
Kaj Blennow University of Gothenburg
Christian Haass
Christian Haass Ludwig-Maximilians-Universität München
Arun L.W. Bokde
Arun L.W. Bokde Trinity College Dublin
Michael W. Weiner
Michael W. Weiner University of California, San Francisco
Michael T. Heneka
Michael T. Heneka University Hospital Bonn
Oliver Peters
Oliver Peters German Center for Neurodegenerative Diseases
Henrik Zetterberg
Henrik Zetterberg University of Gothenburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Michael Ewers

Trending Scientists